Stada
Stada Arzneimittel AG, commonly known as Stada, is a prominent player in the global pharmaceutical industry, headquartered in Bad Vilbel, Germany. Founded in 1895, the company has established a strong presence in Europe and beyond, focusing on generic and over-the-counter (OTC) products. Stada's commitment to quality and accessibility has led to significant milestones, including strategic acquisitions that enhance its product portfolio. The company offers a diverse range of pharmaceuticals, including prescription medications and consumer health products, distinguished by their affordability and reliability. Stada's innovative approach to healthcare solutions has positioned it as a trusted name in the market, with notable achievements in expanding its international footprint and enhancing patient access to essential medicines.
DitchCarbon Score
How does Stada's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Instruments industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Stada's score of 33 is higher than 66% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Stada's reported carbon emissions
In 2023, Stada Arzneimittel AG reported total carbon emissions of approximately 99,238,000 tonnes CO2e, comprising 42,696,000 tonnes CO2e from Scope 1 and 56,542,000 tonnes CO2e from Scope 2 emissions. Notably, the company also reported significant Scope 3 emissions, estimated at about 900,000,000 tonnes CO2e. Over the past few years, Stada has made strides in reducing its emissions. In 2022, total emissions were around 109,954,000 tonnes CO2e, indicating a reduction in emissions by approximately 10,716,000 tonnes CO2e from 2022 to 2023. The company has also shown a consistent decrease in emissions from 2020, when total emissions were 131,619,000 tonnes CO2e. Stada has committed to various climate initiatives, although specific reduction targets have not been detailed. The company is actively engaged in sustainability efforts, as evidenced by its participation in the CDP (formerly Carbon Disclosure Project), where it has received varying scores, including a "C" in 2023. While Stada has not yet committed to a net-zero target, it has established near-term reduction commitments. Overall, Stada's emissions data reflects a proactive approach to managing its carbon footprint within the pharmaceutical sector, with ongoing efforts to enhance sustainability practices.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Add to project2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Scope 1 | 31,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 2 | 112,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | - | - | - | - | 000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Stada is committed to some reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
